US 12,478,634 · Application 18/438,820 · Granted Nov 25, 2025
US 12,478,634
Compositions and methods for treating muscular dystrophy and other disorders
Estimated expiration
December 14, 2037
11y 92d remaining
- Could not download TD document MEBVHRUI137X171:
Earliest effective filing
Dec 14, 2017
+ 20 years
Dec 14, 2037
PTA +0d
Dec 14, 2037
No TD
—
Final
Dec 14, 2037
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- February 12, 2024
- Earliest effective filing
- December 14, 2017
- Issue date
- November 25, 2025
- PTA
- 0 days
- Base expiry (before PTA)
- December 14, 2037
December 14, 2017 + 20 years = December 14, 2037
- Continuation of application 17/222,662, filed Apr 5, 2021, issued as US 11,931,371
- Continuation of application 16/554,338, filed Aug 28, 2019, issued as US 10,993,954
- Continuation of application 16/112,447, filed Aug 24, 2018, issued as US 10,434,113
- Continuation-in-part of application 15/842,580, filed Dec 14, 2017, issued as US 10,245,235
- Continuation-in-part of application 15/842,580, filed Dec 14, 2017, issued as US 10,245,235
- Continuation of application 16/112,447, filed Aug 24, 2018, issued as US 10,434,113
- Continuation-in-part of application 15/842,580, filed Dec 14, 2017, issued as US 10,245,235
- Continuation of application 16/554,338, filed Aug 28, 2019, issued as US 10,993,954
- Continuation of application 16/112,447, filed Aug 24, 2018, issued as US 10,434,113
- Continuation-in-part of application 15/842,580, filed Dec 14, 2017, issued as US 10,245,235
- PRO62/520,252 — Provisional — not used for base term
- PRO62/435,442 — Provisional — not used for base term
- PRO62/520,252 — Provisional — not used for base term
- PRO62/435,442 — Provisional — not used for base term
- PRO62/520,252 — Provisional — not used for base term
- PRO62/435,442 — Provisional — not used for base term
- PRO62/435,442 — Provisional — not used for base term
- PRO62/520,252 — Provisional — not used for base term
- PRO62/520,252 — Provisional — not used for base term
- PRO62/435,442 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 18/438,820 · US 12,478,634
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 12,478,634: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US12478634Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.